Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Cash from Investing Activities
Glenmark Life Sciences Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Cash from Investing Activities
-₹1.5B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Investing Activities
-₹54.9B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Investing Activities
-₹25.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Investing Activities
-₹55.9B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Investing Activities
₹10B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Cash from Investing Activities
-₹10.5B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Glenmark Life Sciences Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.5B
INR
Based on the financial report for Mar 31, 2023, Glenmark Life Sciences Ltd's Cash from Investing Activities amounts to -1.5B INR.
What is Glenmark Life Sciences Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-45%
Over the last year, the Cash from Investing Activities growth was -26%. The average annual Cash from Investing Activities growth rates for Glenmark Life Sciences Ltd have been -45% over the past three years .